Teza Capital Management’s DexCom DXCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-9,106
Closed -$604K 91
2025
Q4
$604K Buy
+9,106
New +$589K 1.95% 12
2025
Q3
Sell
-9,456
Closed -$825K 123
2025
Q2
$825K Sell
9,456
-8,401
-47% -$659K 0.62% 30
2025
Q1
$1.22M Buy
17,857
+3,776
+27% +$308K 0.56% 35
2024
Q4
$1.1M Sell
14,081
-14,550
-51% -$1.08M 0.17% 166
2024
Q3
$1.92M Buy
28,631
+20,297
+244% +$1.67M 0.21% 145
2024
Q2
$945K Buy
+8,334
New +$1.05M 0.12% 249
2024
Q1
Sell
-10,274
Closed -$1.27M 607
2023
Q4
$1.27M Buy
10,274
+580
+6% +$59.3K 0.21% 147
2023
Q3
$904K Buy
+9,694
New +$1.09M 0.15% 203
2023
Q1
Sell
-8,744
Closed -$990K 554
2022
Q4
$990K Buy
8,744
+4,735
+118% +$520K 0.19% 176
2022
Q3
$323K Buy
4,009
+1,278
+47% +$108K 0.07% 403
2022
Q2
$204K Buy
+2,731
New +$249K 0.08% 389
2018
Q4
Sell
-39,648
Closed -$1.42M 369
2018
Q3
$1.42M Sell
39,648
-23,724
-37% -$736K 0.33% 105
2018
Q2
$1.5M Buy
+63,372
New +$1.34M 0.22% 144

Other funds holding DXCM

Teza Capital Management's DXCM Position: Q1 2026 in Review

Teza Capital Management sold out of DexCom (DXCM) in Q1 2026, closing a stake of 9,106 shares — an estimated $604K sold.

Teza Capital Management first reported a position in DXCM in Q2 2018 and held it in 13 quarters. The position peaked at $1.92M in Q3 2024. 960 funds tracked by Wall St. Rank hold DXCM as of Q1 2026.

  • Teza Capital Management reported no remaining DexCom position as of Q1 2026 after selling out during the quarter.
  • Teza Capital Management sold 9,106 DexCom shares in Q1 2026, an estimated $604K.
  • Teza Capital Management first reported a position in DexCom in Q2 2018 and held it in 13 quarters.
  • Teza Capital Management's DexCom position peaked at $1.92M in Q3 2024.
  • 960 funds tracked by Wall St. Rank held DexCom as of Q1 2026.

Based on Teza Capital Management's 13F filing for Q1 2026, filed 15 May 2026.